ArticlePloS one2014
Epidemiology of visceral leishmaniasis in Algeria: an update.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.
- Human Leishmaniasis in Algeria: A Systematic Review and Meta-Analysis.Acta parasitologica · 2025Pooled it
- Pooled it
- Algerian leishmaniasis history.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025Review
- A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria.Journal of parasitology research · 2025Review
- Epidemiological profile of visceral leishmaniasis in northern Morocco (2009-2018).The Pan African medical journal · 2024Article
- Geographic distribution of human leishmaniasis and phlebotomine sand flies in the State of Mato Grosso do Sul, Brazil.Parasites & vectors · 2022Article
- Updates on Geographical Dispersion ofPathogens (Basel, Switzerland) · 2021Article
- Univariate associations between housing, management, and facility design factors and the prevalence of lameness lesions in fourteen small-scale dairy farms in Northeastern Algeria.Veterinary world · 2020Article
- Phlebotomine sand flies and Leishmania species in a focus of cutaneous leishmaniasis in Algeria.PLoS neglected tropical diseases · 2020Article
- Antioxidant and Leishmanicidal Evaluation ofPathogens (Basel, Switzerland) · 2019Article
- Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.PLoS neglected tropical diseases · 2018Article
- Cost-effectiveness of diagnostic-therapeutic strategies for paediatric visceral leishmaniasis in Morocco.BMJ global health · 2017Article
- Identification of Algerian Field-Caught Phlebotomine Sand Fly Vectors by MALDI-TOF MS.PLoS neglected tropical diseases · 2016Article
- Visceral Leishmaniasis in Rural Areas of Alborz Province of Iran and Implication to Health Policy.The Korean journal of parasitology · 2015Article
- Estimation of canine Leishmania infection prevalence in six cities of the Algerian littoral zone using a Bayesian approach.PloS one · 2015Article
- The Seroprevalence of Canine Leishmaniasis and a Retrospective Survey of Human Leishmaniasis in the Constantine Region of Algeria.Iranian journal of parasitologyArticle
- Seroepidemiological Study of Visceral Leishmaniasis (Kala-Azar) in Children under 12 Years Old in North of Iran: An Observational Study in 2019-2020.Iranian journal of parasitologyArticle
- Mediterranean visceral leishmaniasis : update on biological diagnosis.La Tunisie medicaleArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral leishmaniasis (VL), a zoonotic disease caused by Leishmania infantum, is endemic in Algeria. This report describes a retrospective epidemiological study conducted on human VL to document the epidemiological profile at national level. All human VL cases notified by the National Institute of Public Health between 1998 and 2008 were investigated. In parallel all VL cases admitted to the university hospitals of Algiers were surveyed to estimate the underreporting ratio. Fifteen hundred and sixty-two human VL cases were reported in Algeria between 1998-2008 with an average annual reported incidence rate of 0.45 cases per 100,000 inhabitants, of which 81.42% were in the age range of 0-4 years. Cases were detected year-round, with a peak notification in May and June. One hundred and seventy patients were admitted to the university hospitals in Algiers in the same period, of which less than one in ten had been officially notified. Splenomegaly, fever, pallor and pancytopenia were the main clinical and laboratory features. Meglumine antimoniate was the first-line therapy for paediatric VL whereas the conventional amphotericin B was used for adult patients. Visceral leishmaniasis in Algeria shows the epidemiological profile of a paediatric disease with a decrease of the annual reported incidence rate. However, vigilance is required because of huge underreporting and an apparent propagation towards the south.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.